Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ending on September 30, 2026.

September 25, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Intimation of Board Meeting and Closure of Trading Window Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, This is to inform you that a meeting of the Board of Directors is scheduled to be held on Wednesday, November 04, 2026, to inter-alia consider and approve the un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half Year ending on September 30, 2026. Further, in accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company shall be closed from October 1, 2026, to November 06, 2026 (both days inclusive). We request you to kindly take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer